Doctors around the world are using iPhone to transform the way we think about health. Apps created with ResearchKit are already producing medical insights and discoveries at a pace and scale never seen before.
That success has inspired us to widen the scope from medical research to personal care with the introduction of CareKit — a framework for developers to build apps that let you manage your own well-being on a daily basis. For medical researchers, the first step to battling disease is understanding it. ResearchKit is helping researchers achieve that goal. An open source framework for building apps, ResearchKit makes it easier to enroll participants and conduct studies. With the mPower app, Melinda Penkava can track her condition on a daily basis and share the information with her care team — from wherever she happens to be.
The biggest challenge medical researchers face is recruiting participants. Often just a handful of people are used in a study. But the sheer number of iPhone users around the globe means that apps built on ResearchKit can enroll participants and gather data in bigger numbers than ever. You no longer have to travel to a hospital or facility to complete tasks and fill out questionnaires.
In a short amount of time, the apps built on ResearchKit have helped medical institutions enroll an unprecedented number of participants in their studies. Research has shown that early treatment of developmental issues can lead to higher IQs and better social skills. And children can be screened without having to see a specialist in person, allowing for earlier diagnosis and treatment. Since its launch, the EpiWatch app has enabled people to accurately track the onset and duration of seizures in real time, creating a correlation between episode history and medication.
Researchers are using the SleepHealth app to identify connections between sleep habits and conditions such as diabetes, heart disease, obesity, COPD, and depression. With the right tools, you can play an active role in managing your own health. The EpiWatch app lets you send a notification to a loved one when a seizure is coming on.
Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document. This article is written by an independent contributor of RDInvesting. For more information please read our full disclaimer at www. For any questions, inquiries, or comments reach out to us directly at:.
Experts discuss the challenges facing the world. Shares have outperformed the industry on a year-to-date basis. Nevertheless, significant competition in most of its operating markets and strong demand for feature-rich smartphones at a much cheaper price are major headwinds for the company.
The company posted its 13th consecutive earnings beat in fourth-quarter fiscal Further, it is benefiting from higher demand for skincare products, along with fabric and home care products. However, the company is witnessing strained margins owing to increased commodity and shipping costs, adverse currency, higher business investments and aggressive pricing from private-label products amid intense competition.
Moreover, sales remain muted due to weak demand and lower prices. Further, the company possesses an impressive earnings surprise history, beating the Zacks Consensus Estimate in all the trailing four quarters. Moreover, controlled expenses were experienced. Recently, the capital plan approval reflects strong capital position.
Yet several issues, including litigation burden, keep us apprehensive. Today's Stocks from Zacks' Hottest Strategies. It's hard to believe, even for us at Zacks. And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From - , the composite yearly average gain for these strategies has beaten the market more than 19X over.
Find the latest analyst research for Apple Inc. (AAPL) at reynaldaeryeagley.tk
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.. The ever popular one-page Snapshot reports are generated for virtually every single.
Aug 24, · Research reports on APPLE INC (AAPL) from S&P Compustate and others. Skip to Main Content. Site navigation independent research reports. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus. Established in in California, Apple Inc. is a global designer, manufacturer and marketer of mobile communication and media devices, personal computers, and portable digital music players. Apple is the largest IT company in the world by revenue and total assets and the second-largest mobile.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Procter & Gamble. This report presents research findings from Year Two of the ACOT Teacher Development Centers project, a model of teacher development that goes beyond the.